FDA approves the Stem Cell Educator Therapy for type 1 diabetes

FDA (The United States Food and Drug Administration) approved the Phase I/II clinical trial of Stem Cell Educator therapy for the treatment of type 1 diabetic patients at Hackensack University Medical Center. This big milestone achieved by Dr. Yong Zhao and his team will open up new avenues for the clinical treatment of diabetes and other autoimmune diseases